Boston, MA 08/19/2014 (wallstreetpr) – Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) has appointed Mr. Tiago Girão as Chief Financial Officer and VP of Finance, effective from September 2, 2014. He is considered as an ideal candidate to take over the new role at the time of corporate development. He has got a strong professional background in the public company as well as in international operations. The experience of finance and accounting practices at international level adds to the expertise of Mr. Girão.
The key highlights
Mr. Girão has got the experience and expertise of working with varied firms. Also, he has got the in-depth knowledge of technology of Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX). He is acquainted with the history of Cytori as he has worked with KPMG where he was on the profile of senior account manager for Cytori. The existing knowledge will help him to understand the process quickly. Dr. Hedrick said that Cytori is excited to have Mr. Girão in the team.
The thoughts
Mr. Girão shared his thoughts on becoming the CFO of Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX). He said that he had followed Cytori and its groundbreaking technology from more than eight years. The technology is impressive that has the potential to transform patients’ lives. He added that he is completely committed to strengthen the global financial operations and the balance sheet of Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX).
The past experiences
Mr. Girão has worked with NuVasive, Inc. as International Controller. He used to lead a 20 person finance team. He was responsible for keeping a check on aspects of international finance as well as accounting operations. He was a part of all major asset acquisitions. He worked as the corporate financial and accounting head for NuVasive’s foreign units in Latin America, Australia, Japan and Europe. Before starting his role as International Controller with NuVasive, Inc. he was on the profile of Director, Financial Reporting with the same company. He used to look after the SEC related matters and handled the corporate technical accounting.
